Multiple pathways regulate Cten in colorectal cancer without a Tensin switch.

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Signaling

Background:

• CTEN/TNS4, a member of the Tensin gene family, localizes to focal adhesions and influences cell motility.
• Mechanisms regulating CTEN expression are not fully understood, with prior evidence suggesting Kras involvement in colon and pancreas.
• In normal mammary cells, CTEN is reportedly upregulated by epidermal growth factor receptor (EGFR) and STAT3 signaling, linked to Tensin 3 downregulation (Tensin switch).

Purpose of the Study:

• To investigate the roles of EGFR and STAT3 signaling in regulating CTEN expression within colorectal cancer (CRC).
• To explore the involvement of calpain, a focal adhesion-associated protein regulator, in CTEN function.
• To clarify the interaction between CTEN and Tensin 3 in CRC.

Main Methods:

• Stimulation of CRC cell lines with epidermal growth factor (EGF).
• Knockdown of Kras and manipulation of STAT3 signaling (activation and knockdown).
• Inhibition of calpain activity and assessment of CTEN and Tensin 3 protein levels.
• Forced expression or knockdown of CTEN to evaluate its effect on Tensin 3.

Main Results:

• EGF stimulation increased CTEN and Tensin 3 protein levels.
• Kras knockdown decreased both CTEN and Tensin 3.
• STAT3 activation downregulated CTEN, while STAT3 knockdown upregulated it.
• Calpain inhibition led to increased CTEN and Tensin 3.
• CTEN manipulation directly affected Tensin 3 levels, with overexpression upregulating and knockdown downregulating Tensin 3.

Conclusions:

• In colorectal cancer, CTEN is upregulated by EGFR and Kras signaling pathways.
• STAT3 signaling acts as a negative regulator of CTEN in CRC.
• Calpain may function as a negative regulator of CTEN.
• A 'Tensin switch' does not occur in CRC; instead, CTEN appears to stabilize Tensin 3.